FCE
IRWD icon

Fiera Capital (Europe)’s Ironwood Pharmaceuticals IRWD Stock Holding History

Fiera Capital (Europe)’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-6,663
Closed -$58K – 52
2015
Q3 		$58K Hold
6,663
– – 0.08% 52
2015
Q2 		$67K Buy
+6,663
New +$77.4K 0.06% 49

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
Rubric Capital Management (Connecticut) Stamford, Connecticut $6.44M AUM 43.01% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Fiera Capital (Europe)'s IRWD Position: Q4 2015 in Review

Fiera Capital (Europe) sold out of Ironwood Pharmaceuticals (IRWD) in Q4 2015, closing a stake of 6,663 shares — an estimated $58K sold.

Fiera Capital (Europe) first reported a position in IRWD in Q2 2015 and held it in 2 quarters. The position peaked at $67K in Q2 2015. 137 funds tracked by Wall St. Rank hold IRWD as of Q4 2015.

  • Fiera Capital (Europe) reported no remaining Ironwood Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Fiera Capital (Europe) sold 6,663 Ironwood Pharmaceuticals shares in Q4 2015, an estimated $58K.
  • Fiera Capital (Europe) first reported a position in Ironwood Pharmaceuticals in Q2 2015 and held it in 2 quarters.
  • Fiera Capital (Europe)'s Ironwood Pharmaceuticals position peaked at $67K in Q2 2015.
  • 137 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q4 2015.

Based on Fiera Capital (Europe)'s 13F filing for Q4 2015, filed 16 Feb 2016.